241 related articles for article (PubMed ID: 2690072)
1. Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors.
Dreyer GB; Metcalf BW; Tomaszek TA; Carr TJ; Chandler AC; Hyland L; Fakhoury SA; Magaard VW; Moore ML; Strickler JE
Proc Natl Acad Sci U S A; 1989 Dec; 86(24):9752-6. PubMed ID: 2690072
[TBL] [Abstract][Full Text] [Related]
2. Hydroxyethylene isostere inhibitors of human immunodeficiency virus-1 protease: structure-activity analysis using enzyme kinetics, X-ray crystallography, and infected T-cell assays.
Dreyer GB; Lambert DM; Meek TD; Carr TJ; Tomaszek TA; Fernandez AV; Bartus H; Cacciavillani E; Hassell AM; Minnich M
Biochemistry; 1992 Jul; 31(29):6646-59. PubMed ID: 1637805
[TBL] [Abstract][Full Text] [Related]
3. Small dipeptide-based HIV protease inhibitors containing the hydroxymethylcarbonyl isostere as an ideal transition-state mimic.
Kiso Y; Matsumoto H; Mizumoto S; Kimura T; Fujiwara Y; Akaji K
Biopolymers; 1999; 51(1):59-68. PubMed ID: 10380353
[TBL] [Abstract][Full Text] [Related]
4. Studies of human immunodeficiency virus type 1 (HIV-1) protease inhibitors. III. Structure-activity relationship of HIV-1 protease inhibitors containing cyclohexylalanylalanine hydroxyethylene dipeptide isostere.
Sakurai M; Higashida S; Sugano M; Handa H; Komai T; Yagi R; Nishigaki T; Yabe Y
Chem Pharm Bull (Tokyo); 1994 Mar; 42(3):534-40. PubMed ID: 8004698
[TBL] [Abstract][Full Text] [Related]
5. Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor.
Jaskólski M; Tomasselli AG; Sawyer TK; Staples DG; Heinrikson RL; Schneider J; Kent SB; Wlodawer A
Biochemistry; 1991 Feb; 30(6):1600-9. PubMed ID: 1993177
[TBL] [Abstract][Full Text] [Related]
6. Role of hydroxyl group and R/S configuration of isostere in binding properties of HIV-1 protease inhibitors.
Petroková H; Dusková J; Dohnálek J; Skálová T; Vondrácková-Buchtelová E; Soucek M; Konvalinka J; Brynda J; Fábry M; Sedlácek J; Hasek J
Eur J Biochem; 2004 Nov; 271(22):4451-61. PubMed ID: 15560786
[TBL] [Abstract][Full Text] [Related]
7. Purification and biochemical characterization of recombinant simian immunodeficiency virus protease and comparison to human immunodeficiency virus type 1 protease.
Grant SK; Deckman IC; Minnich MD; Culp J; Franklin S; Dreyer GB; Tomaszek TA; Debouck C; Meek TD
Biochemistry; 1991 Aug; 30(34):8424-34. PubMed ID: 1883829
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 protease inhibitors: ketomethylene isosteres with unusually high affinity compared with hydroxyethylene isostere analogs.
Marinier A; Toth MV; Houseman K; Mueller R; Marshall GR
Bioorg Med Chem; 1994 Sep; 2(9):919-25. PubMed ID: 7712127
[TBL] [Abstract][Full Text] [Related]
9. 15gag proteinase of myeloblastosis-associated virus: specificity studies with substrate-based inhibitors.
Pavlícková L; Stys D; Soucek M; Urban J; Hrusková O; Sedlácek J; Strop P
Arch Biochem Biophys; 1992 Nov; 298(2):753-6. PubMed ID: 1417001
[TBL] [Abstract][Full Text] [Related]
10. Peptide substrates and inhibitors of the HIV-1 protease.
Moore ML; Bryan WM; Fakhoury SA; Magaard VW; Huffman WF; Dayton BD; Meek TD; Hyland L; Dreyer GB; Metcalf BW
Biochem Biophys Res Commun; 1989 Mar; 159(2):420-5. PubMed ID: 2649094
[TBL] [Abstract][Full Text] [Related]
11. Proteolysis of an active site peptide of lactate dehydrogenase by human immunodeficiency virus type 1 protease.
Tomaszek TA; Moore ML; Strickler JE; Sanchez RL; Dixon JS; Metcalf BW; Hassell A; Dreyer GB; Brooks I; Debouck C
Biochemistry; 1992 Oct; 31(42):10153-68. PubMed ID: 1420138
[TBL] [Abstract][Full Text] [Related]
12. Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor.
Copeland TD; Wondrak EM; Tozser J; Roberts MM; Oroszlan S
Biochem Biophys Res Commun; 1990 May; 169(1):310-4. PubMed ID: 2190554
[TBL] [Abstract][Full Text] [Related]
13. Substitutions at the P2' site of gag p17-p24 affect cleavage efficiency by HIV-1 protease.
Margolin N; Heath W; Osborne E; Lai M; Vlahos C
Biochem Biophys Res Commun; 1990 Mar; 167(2):554-60. PubMed ID: 2182016
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of HIV type 1 infection of mononuclear phagocytes by synthetic peptide analogs of HIV type 1 protease substrates.
Dukes CS; Matthews TJ; Lambert DM; Dreyer GB; Petteway SR; Weinberg JB
AIDS Res Hum Retroviruses; 1996 Jun; 12(9):777-82. PubMed ID: 8738429
[TBL] [Abstract][Full Text] [Related]
15. A rational approach in the search for potent inhibitors against HIV proteinase.
Hui KY; Manetta JV; Gygi T; Bowdon BJ; Keith KA; Shannon WM; Lai MH
FASEB J; 1991 Aug; 5(11):2606-10. PubMed ID: 1868985
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of substrate-based peptidomimetic human immunodeficiency virus protease inhibitors containing the hydroxymethylcarbonyl isostere.
Kiso Y
Biopolymers; 1996; 40(2):235-44. PubMed ID: 8785365
[TBL] [Abstract][Full Text] [Related]
17. Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library.
Carroll CD; Patel H; Johnson TO; Guo T; Orlowski M; He ZM; Cavallaro CL; Guo J; Oksman A; Gluzman IY; Connelly J; Chelsky D; Goldberg DE; Dolle RE
Bioorg Med Chem Lett; 1998 Sep; 8(17):2315-20. PubMed ID: 9873534
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 protease in infected T-lymphocytes by synthetic peptide analogues.
Meek TD; Lambert DM; Dreyer GB; Carr TJ; Tomaszek TA; Moore ML; Strickler JE; Debouck C; Hyland LJ; Matthews TJ
Nature; 1990 Jan; 343(6253):90-2. PubMed ID: 1688646
[TBL] [Abstract][Full Text] [Related]
19. Narrow substrate specificity and sensitivity toward ligand-binding site mutations of human T-cell Leukemia virus type 1 protease.
Kádas J; Weber IT; Bagossi P; Miklóssy G; Boross P; Oroszlan S; Tözsér J
J Biol Chem; 2004 Jun; 279(26):27148-57. PubMed ID: 15102858
[TBL] [Abstract][Full Text] [Related]
20. Studies of HIV-1 protease inhibitors. II. Incorporation of four types of hydroxyethylene dipeptide isosteres at the scissile site of substrate sequences.
Sakurai M; Higashida S; Sugano M; Nishi T; Saito F; Ohata Y; Handa H; Komai T; Yagi R; Nishigaki T
Chem Pharm Bull (Tokyo); 1993 Aug; 41(8):1378-86. PubMed ID: 8403086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
